Antitubercular drugs: new drugs designed by molecular modifications
نویسندگان
1 دانشگاه صنعتی شاهرود
2
doi
10.22034/ajgc.2022.4.4چکیده
Tuberculosis is a long-term infection caused by the bacteria Mycobacterium tuberculosis . Long-term TB treatment has several drawbacks, including medication resistance, noncompliance with therapy, and a scarcity of therapeutic options. It is critical to find new medications that are both safer and more effective. Molecular modification is a valuable method for identifying novel chemicals that can overcome these obstacles. The primary tactics to obtain a novel anti-tubercular medication are summarized in this paper.